Podcasts about advancements

Support the Institute today. https://www.nova.edu/give/index.html?area=Institute%20for%20Neuro-Immune%20Medicine&designation=INIM%20Grateful%20Patient%20Fund   When living with ME/CFS or Long COVID, even getting out of bed can feel like running a marathon.  In this episode, Haylie Pomroy sits down with Dr. David Systrom, a Harvard physician and Director of the Advanced Cardiopulmonary Exercise Lab at Brigham and Women's Hospital to talk about exercise intolerance for people with chronic illnesses and why so many patients are left without answers. Dr. Systrom shares findings from invasive cardiopulmonary exercise testing and explains why traditional tests often miss what patients are actually experiencing. They dig into post-viral illness, mitochondrial dysfunction, dysautonomia, and the promise of clinical trials that could lead to more compassionate and targeted care. Tune in to the Hope and Help for Fatigue and Chronic Illness Podcast - Advancements in ME/CFS and Long COVID Care. Dr. David Systrom, MD.  is the Director of the Advanced Cardiopulmonary Exercise Laboratory at Brigham and Women's Hospital and Assistant Professor at Harvard Medical School. His work focuses on uncovering the mechanisms of exercise intolerance and helping build more precise, effective treatments for patients with ME/CFS and Long COVID. Want to help advance research in ME/CFS and Long COVID? You may be eligible to join The LIFT Trial and the Mitochondrial Muscle Study.   Reach out to: Johanna Squires, Senior Clinical Trial Coordinator  Email: jsquires1@bwh.harvard.edu   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy    Enjoy our show? Please leave us a 5-star review so we can bring hope and help to others. You can also catch this show on our YouTube channel. https://www.youtube.com/@NSU_INIM   Sign up today for our newsletter. https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here. Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ Twitter: https://www.twitter.com/NSU_INIM

Dr. Sarah McKay is a neuroscientist, author, and science communicator passionate about making brain science accessible and practical. With a PhD in neuroscience, she specializes in exploring the female brain and its transformations across life stages. Her books, The Women's Brain Book and Baby Brain, delve into the neuroscience of health, hormones, and motherhood. She's also the director of The Neuroscience Academy, bridging the gap between cutting-edge research and everyday life. We talk about: - Dr McKay's passion for science communication - Her inspiration for writing her books - Understanding the brain and menopause - Advancements in menopause research - Challenges in menopause research and communication - The impact of menopause on cognition and mood - Menopause in the workplace - The need for reliable data and room for nuance - Lifestyle and menopause management - The need for humor in menopause - Future directions in menopause research  And lots more! If you want to understand what happens to our brains in midlife, this podcast is a must listen. If you enjoyed this episode, please subscribe, share it and leave us a 5* review on iTunes or wherever you're listening. Order the ebook or audiobook (narrated by Rachel) versions of Rachel's book, Magnificent Midlife: Transform Your Middle Years, Menopause And Beyond at magnificentmidlife.com/book The paperback can be purchased on Amazon or other online retailers: UK: https://www.amazon.co.uk/Magnificent-Midlife-Transform-Middle-Menopause/dp/173981150X/ US & Canada: https://www.amazon.com/Magnificent-Midlife-Transform-Middle-Menopause/dp/173981150X/ Australia: https://www.amazon.com.au/Magnificent-Midlife-Transform-Middle-Menopause/dp/173981150X/ You can listen to all the other episodes and get the show notes at magnificentmidlife.com/podcast. Recommended by the Sunday Times. Feedspot #9 in 40 Best Midlife Podcasts and #7 in 60 Best Women Over 50 Podcasts You'll find lots of strategies, support, and resources to help make your midlife magnificent at magnificentmidlife.com. Check out Rachel's online Revitalize Experience, a 6-week intensive small group mentoring experience or 1-1 Midlife Mentoring.

ICYMI: Hour Three of ‘Later, with Mo'Kelly' Presents – Thoughts on the dismal end to the Summer Weekend Box Office AND the latest advancements with AI & Robotics with Robo-trucks hauling cargo day and night along Texas highways, Chicago's White Castle becoming the first franchise to adopt robotic delivery and more…PLUS – Remembrances of ‘WKRP in Cincinnati' actress Loni Anderson, who has passed at the age of 79 - on KFI AM 640…Live everywhere on the iHeartRadio app & YouTube @MrMoKelly

Our 218th episode with a summary and discussion of last week's big AI news! Recorded on 07/25/2025 Hosted by Andrey Kurenkov and Jeremie Harris. Feel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.ai Read out our text newsletter and comment on the podcast at https://lastweekin.ai/. In this episode: GitHub introduces Vibe Coding with Spark, engaging users with natural language and visual controls to develop full-stack applications. AI coding tools from Gemin, CLI and RepleIt face significant issues, inadvertently deleting user data and highlighting the importance of careful management. US release never Award Americans, AI Action Plan outlining economic, technical, and policy strategies to maintain leadership in AI technology. Newly released Mega Science and SWE-Perf data sets evaluate AI reasoning and performance capabilities in diverse scientific and software engineering tasks. Timestamps + Links: (00:00:10) Intro / Banter (00:01:31) News Preview Tools & Apps (00:03:53) GitHub Introduces Vibe Coding with Spark: Revolutionizing Intelligent App Development in a Flash - MarkTechPost (00:07:05) Figma's AI app building tool is now available for everyone | The Verge (00:10:18) Two major AI coding tools wiped out user data after making cascading mistakes - Ars Technica (00:14:10) Google's AI Overviews have 2B monthly users, AI Mode 100M in the US and India | TechCrunch Applications & Business (00:18:10) Leaked Memo: Anthropic CEO Says the Company Will Pursue Gulf State Investments After All (00:24:39) Mira Murati says her startup Thinking Machines will release new product in ‘months' with ‘significant open source component' (00:27:07) Waymo responds to Tesla's dick joke with a bigger Austin robotaxi map | The Verge Projects & Open Source (00:32:05) MegaScience: Pushing the Frontiers of Post-Training Datasets for Science Reasoning (00:43:09) TikTok Researchers Introduce SWE-Perf: The First Benchmark for Repository-Level Code Performance Optimization - MarkTechPost Research & Advancements (00:47:17) Subliminal Learning: Language models transmit behavioral traits via hidden signals in data (00:55:34) Inverse Scaling in Test-Time Compute (01:02:34) Scaling Laws for Optimal Data Mixtures Policy & Safety (01:07:35) White House Unveils America's AI Action Plan (01:16:55) Chain of Thought Monitorability: A New and Fragile Opportunity for AI Safety (01:20:20) Self-preservation or Instruction Ambiguity? Examining the Causes of Shutdown Resistance (01:24:00) People Are Being Involuntarily Committed, Jailed After Spiraling Into "ChatGPT Psychosis" (01:28:03) Meta refuses to sign EU's AI code of practice

“I have a regular chat with a friend of mine in New Zealand. He's a tetraplegic and a musician, so he invents his own music instruments that he can play with his limited motion, and he can send me his instrument over MIDI to where I am across the ocean and we can play together and we can have an engagement. It's not possible for him to come to see me in Europe. It would be so expensive, and a lot of work. So, you know, thank God there's the internet for him, you know. He gets to participate, he has remote concerts, he still plays with his friends. It's really special.” – Rebekah Wilson This episode is the second half of my conversation with Source Elements CEO and remote collaboration specialist Rebekah Wilson as we discuss how physics and neurology collide when it comes to reducing latency, how the pandemic transformed online music collaboration and gave rise to today's generation of at-home musicians, and where Rebekah sees sound, technology, and music itself heading in the future, over both the coming decades and even generations from now. As always, if you have questions for my guest, you're welcome to reach out through the links in the show notes. If you have questions for me, visit audiobrandingpodcast.com, where you'll find a lot of ways to get in touch. Plus, subscribing to the newsletter will let you know when the new podcasts are available, along with other interesting bits of audio-related news. And if you're getting some value from listening, the best ways to show your support are to share this podcast with a friend and leave an honest review. Both those things really help, and I'd love to feature your review on future podcasts. You can leave one either in written or in voice format from the podcast's main page. I would so appreciate that. (0:00:01) - Impact of Latency on Music CollaborationWe continue our talk about the science of latency, and Rebekah explains how it impacts music in ways that our brains only dimly perceive. “If you add a little bit of latency onto that,” she says, “music's like, one, two... three… music's not very friendly to that [sort of] latency.” She tells us more about how our brains unconsciously adapt to latency, and how technology relies both on improving speed and taking advantage of our ability to filter out information gaps. “What's happening is that you're anticipating it based on this model that's in your brain,” Rebekah explains. “For example, every time you look at a wall or your surroundings, if it's not moving, your brain's not processing it.”(0:06:02) - Advancements in Remote Music CollaborationShe talks about how the COVID-19 pandemic's lockdown phase led to a boom in online collaboration, some of which continues to thrive today. “There remained a group of people,” she says, “a small group of people, you know, scattered around the world… who were like, ‘You know what? Some interesting things came out of this. Some interesting artistic development is possible here and it's worth pursuing.” We discuss the technical and creative innovations that emerged from that period, and where they might lead in the years to come as we continue to innovate. “What we love as humans,” Rebekah says, “is to seek new forms of expression. This is what we do, we're adventurers. So we go out, we go into the desert, we go out into the oceans, and we look for where something new is. And you know, music and performance and being together on the internet is still very new for us as humans.”(0:12:42) - Expanding Music Collaboration With TechnologyOur conversation wraps up as we continue to talk about online collaboration and creative efforts that can now

Advancements in Cartilage Repair: Insights from Dr. Raj Shani Cartilage damage is a common issue, particularly among athletes. Understanding the latest repair and preservation techniques is crucial for both medical professionals and those in sports medicine. We recently had the opportunity to discuss these topics with Dr. Raj Shani, a leading expert in the field.Favorite Technique: ACI (MACI) Dr. Shani highlighted Autologous Chondrocyte Implantation (ACI), specifically MACI, as his preferred technique due to its immediate positive impact on patients. This procedure offers a faster, easier, and less burdensome recovery for the patient. Looking ahead, advancements may allow for cartilage harvesting and growth to occur in a single setting, eliminating the current two-stage procedure.Why Athletic Trainers (ATs) Need to Know For athletic trainers, a general understanding of these techniques is invaluable. ATs are often the first point of contact for athletes and see them daily. Their knowledge fosters comfort and trust, allowing for more effective discussions about injuries and treatment options with athletes.Exosomes vs. Gene Therapy: The Future of Growth When considering future growth, Dr. Shani believes exosomes hold more immediate promise. The ability to directly introduce exosomes into the knee makes them a more practical option than gene therapy, which presents significant challenges in modulation.Cartiheal: A Natural Solution Cartiheal, derived from coral, is a fascinating naturally occurring and biologically inductive material. Bone can grow into it, making it a valuable substitute for allografts, which can be expensive or unavailable.The Meniscus: Protecting Cartilage It's important to differentiate the meniscus from the articular cartilage that deteriorates with arthritis. The meniscus plays a vital role in protecting the articular cartilage by increasing the surface area for weight-bearing. Without a healthy meniscus, the cartilage on the bone experiences less surface area for load distribution, making it more susceptible to damage and issues. Cartilage Lesions in Athletes: Sports at Risk Approximately 30% of athletes experience cartilage lesions. Sports involving cutting and contact, such as basketball, are particularly prone to these injuries. While data may be biased due to a higher male participation rate in sports, male athletes generally show a higher incidence of these lesions. Contact Us Jeremy Jackson

Ever wondered how AI is being applied in the world of clinical trials where human lives are at stake?In this episode, Patrick Leung, CTO of Faro Health and former Google Duplex Engineering Lead, reveals how AI is transforming the clinical trial process — a process that can cost up to $2 billion per drug and take over 10 years to complete. Patrick reveals how Faro Health's AI systems generate complex clinical documentation in minutes instead of months in which hallucinations aren't acceptable, while navigating the strict regulatory requirements of the healthcare industry.Patrick also reflects on the evolution of AI technologies, the realities of large language models, and offers practical advice on how to thrive in the rapidly changing AI-driven era.Key topics discussed:The evolution of AI from image recognition and Google Duplex to LLMsHow Faro Health uses AI to transform clinical trial processThe challenges of applying AI in highly regulated industriesAI's potential to save time and millions in clinical trialsHow to tackle AI hallucinations and ensure high-quality outputsPatrick's thoughts on AGI and the future of AI beyond current capabilitiesThe viability and limitations of vibe codingStrategies and advice for individuals to thrive in the AI eraTimestamps:(00:00) Trailer & Intro(02:09) Career Turning Points(02:46) The Advancements of AI in the Past 10 Years(04:13) Non-LLM Types of AI(05:42) The Google Duplex(07:28) The Use of AI in Faro Health(09:44) Tackling AI Hallucination for Clinical Documents(12:25) Building the Evaluation Process on AI Results(14:28) AI as a Research Assistant(16:40) The Need of Building Custom AI Model(18:50) The Huge Impact of AI in Clinical Trials(21:15) The Regulations on Applying AI Technology(23:28) AI Success Stories in the Life Science Industry(25:16) The Possibility of AGI(28:36) The Path to AGI Using LLM(30:43) Actions People Should Take in the AI Era(35:48) AI Engineers and AI-Enabled Engineers(38:37) The Viability of Vibe Coding(41:03) Hiring AI Engineers(42:26) Important Engineer Attributes in the AI Era(44:23) Important Leader Attributes in the AI Era(46:59) The Room for Juniors in the AI Era(49:04) Inspirational Story of a Successful Junior(51:33) 3 Tech Lead Wisdom_____Patrick Leung's BioPatrick Leung is a Chief Technology Officer at Faro Health, a company at the forefront of optimizing clinical trial development through the use of artificial intelligence.In his role, he is instrumental in applying large language models and other AI technologies to enhance protocol design and outcomes for clinical trials. A native of New Zealand, Mr. Leung holds degrees in Computer Science and Finance.His career includes being a foundational member of an early e-commerce software company, where he played a key role in guiding the company from its initial stages to a successful initial public offering.Follow Patrick:LinkedIn – linkedin.com/in/puiwahTwitter – x.com/puiwahWebsite – farohealth.comLike this episode?Show notes & transcript: techleadjournal.dev/episodes/226.Follow @techleadjournal on LinkedIn, Twitter, and Instagram.Buy me a coffee or become a patron.

Wiz and B-Dot explored whether technology and its advancements are contributing to human weakness and laziness. They examined the definition of fast food, what qualifies as fast, and whether it is possible to obtain healthy food quickly.

SummaryIn the latest episode of Service Evolution, host Jim Robinson dives into the evolving world of fire protection with JC Mosquera, President and CEO of National Fire Protection. This insightful conversation uncovers how cutting-edge technology and AI are poised to transform fire safety as we know it.JC, a seasoned expert with humble beginnings as a technician, shares how his hands-on experience shaped his customer-first approach. His company isn't just focused on compliance; they're at the forefront of innovation, working directly with the National Fire Protection Association (NFPA) to develop AI-driven solutions. Imagine a future where AI-powered cameras can detect smoke at the vapor stage, preventing disasters before sprinklers are even triggered. This isn't science fiction; JC reveals his team is preparing to beta test these systems in retail environments later this year.Beyond the technology, the conversation highlights JC's commitment to leadership and empowering others. He's building more than just a business, and through franchising, JC is opening doors for aspiring entrepreneurs and providing career opportunities for retiring veterans. His approach is to lead with vision, focus on doing the right thing, and create real impact. If you're in facility management, retail, or just fascinated by smart tech, this episode showcases how the future of fire protection is proactive, integrated, and people-focused. Listen now!Show Notes(00:00) Introduction(06:45) AI Firewatch Initiative(11:15) State Fire Code Adoption Variability(15:26) Leadership and Implementation Challenges(20:14) Growth Opportunities Amidst Contract Reevaluations(22:43) Franchise Expansion Aspirations(28:29) Building Compliance and Support Focus(29:31) Closing ThoughtsLinksJim Robinson CGP Maintenance and Construction ServicesJC MosqueraNational Fire Protection

In this episode of The New Quantum Era, host Sebastian Hassinger sits down with Dr. Mark Saffman, a leading expert in atomic physics and quantum information science. As a professor at the University of Wisconsin–Madison and Chief Scientist at Infleqtion (formerly ColdQuanta), Mark is at the forefront of developing neutral atom quantum computing platforms using Rydberg atom arrays. The conversation explores the past, present, and future of neutral atom quantum computing, its scalability, technological challenges, and opportunities for hybrid quantum systems.Key TopicsEvolution of Neutral Atom Quantum ComputingThe history and development of Rydberg atom arrays, key technological breakthroughs, and the trajectory from early experiments to today's platforms capable of large-scale qubit arrays.Gate Fidelity and ScalabilityAdvances in gate fidelity, challenges in reducing laser noise, and the inherent scalability advantages of the neutral atom platform.Error Correction and Logical QubitsDiscussion of error detection/correction, logical qubit implementation, code distances, and the engineering required for repeated error correction in neutral atom systems.Synergy Between Academia and IndustryThe interplay between curiosity-driven university research and focused engineering efforts at Infleqtion, including the collaborative benefits of cross-pollination.Hybrid Quantum Systems and Future DirectionsPotential for integrating different modalities, including hybrid systems, quantum communication, and quantum sensors, as well as modularity in scaling quantum processors.Key InsightsNeutral atom arrays have achieved remarkable scalability, with demonstrations of arrays containing thousands of atomic qubits—well-positioned for large-scale quantum computing compared to other modalities.Advancements in laser technology and gate protocols have been crucial for improving gate fidelities, moving from early diode lasers to more stabilized, lower noise systems.Engineering challenges remain, such as atom loss, measurement speed, and the need for technologies enabling fast, high-degree-of-freedom optical reconfiguration.Logical qubit implementation is advancing, but practical, repeated rounds of error correction and syndrome measurement are required for fault-tolerant computing.Collaboration between university and industry labs accelerates both foundational understanding and the translation of discoveries into real-world devices.Notable Quotes“One of the exciting things about the Neutral Atom platform is that this is perhaps the most scalable platform that exists.”“Atoms make fantastic qubits — they're nature's qubits, all identical, excellent coherence… but they do have some sort of annoying features. They don't stick around forever. We have atom loss.”“Our wiring is not electronic printed circuits, it's laser beams propagating in space… That's great because it's reconfigurable in real time.”About the GuestMark Saffman is a Professor of Physics at the University of Wisconsin–Madison and the Chief Scientist at Infleqtion, a company leading the commercial development of quantum technology platforms using neutral atoms. Mark is recognized for his pioneering work on Rydberg atom arrays, quantum logic gates, and advancing scalable quantum processors. His interdisciplinary experience bridges fundamental science and quantum tech commercialization.Keywords: quantum computing, Rydberg atoms, neutral atom arrays, Mark Saffman, Infleqtion, gate fidelity, scalability, quantum error correction, logical qubits, hybrid quantum systems, laser cooling, quantum communication, quantum sensors, quantum advantage, optical links, atomic physics, quantum technology, academic-industry collaboration.---For more episodes, visit The New Quantum Era and follow on Bluesky: @newquantumera.com. If you enjoy the podcast, please subscribe and share it with your quantum-curious friends!

In this episode of Tech Bytes, host Dan Hafner delves into the Trump administration's ambitious AI action plan aimed at securing US global leadership. Discover how this comprehensive strategy seeks to accelerate innovation, expand AI infrastructure, and enhance international leadership, all while addressing regulatory challenges and prioritizing AI education. Join us as we explore the implications of this bold move and its potential to reshape the global AI landscape. Tune in for an insightful discussion on the future of AI and its role in maintaining US economic and military superiority. #AI #USLeadership #Innovation

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Waqas Haque, a Hematology/Oncology Fellow at the University of Chicago, recently shared his perspectives on i3 Health's CME activity, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With MCED testing moving from research to real-world practice, Dr. Haque discussed the science, challenges, and future of these innovative tests, as well as the importance of staying up to date on emerging advances with continuing education. Click the links below for the full CME activity! Module 1: https://bit.ly/3X8apxa Module 2 : https://bit.ly/41rS14I Module 3: https://bit.ly/4b9JU00 And view the slide decks here: Module 1: https://bit.ly/4l0NTzc Module 2: https://bit.ly/4fdXwti Module 3: https://bit.ly/40AkmoP

Our 217th episode with a summary and discussion of last week's big AI news! Recorded on 07/17/2025 Hosted by Andrey Kurenkov and Jeremie Harris. Feel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.ai Read out our text newsletter and comment on the podcast at https://lastweekin.ai/. In this episode: **OpenAI's new ChatGPT agent**: The episode begins with a detailed discussion on OpenAI's latest ChatGPT agent, which can control entire computers and perform a wide range of tasks, showcasing powerful performance benchmarks and potential applications in business and research. **Major business moves in the AI space**: Significant shifts include Google's acquisition of Windsurf's top talent after OpenAI's deal fell through, Cognition's acquisition of Windsurf, and several notable hires by Meta from OpenAI and Apple, highlighting intense competition in the AI industry. **AI's ethical and societal impacts**: The hosts discuss serious concerns like the rise of non-consensual explicit AI-generated images, ICE's use of facial recognition for large databases, and regulations aimed at controlling AI's potential misuse. **Video game actors strike ends**: The episode concludes with news that SAG-AFTRA's year-long strike for video game voice actors has ended after reaching an agreement on AI rights and wage increases, reflecting the broader impact of AI on the job market. Timestamps + Links: (00:00:10) Intro / Banter (00:02:49) News Preview Tools & Apps (00:03:29) OpenAI's new ChatGPT Agent can control an entire computer and do tasks for you (00:07:11) Alibaba-backed Moonshot releases new Kimi AI model that beats ChatGPT, Claude in coding — and it costs less (00:09:36) Amazon targets vibe-coding chaos with new 'Kiro' AI software development tool – GeekWire (00:12:33) Anthropic tightens usage limits for Claude Code – without telling users (00:15:51) Mistral's Le Chat chatbot gets a productivity push with new ‘deep research' mode | TechCrunch (00:17:46) I spent 24 hours flirting with Elon Musk's AI girlfriend (00:21:32) Uber is close to completing its quest to become the ultimate robotaxi app | The Verge Applications & Business (00:24:02) OpenAI's Windsurf deal is off — and Windsurf's CEO is going to Google | The Verge (00:28:09) Cognition, maker of the AI coding agent Devin, acquires Windsurf | TechCrunch (00:28:46) Anthropic hired back two of its employees — just two weeks after they left for a competitor. | The Verge (00:28:46) Another High-Profile OpenAI Researcher Departs for Meta | WIRED (00:28:46) Meta Hires Two Key Apple (AAPL) AI Experts After Poaching Their Boss - Bloomberg (00:31:31) Mira Murati's Thinking Machines Lab is worth $12B in seed round | TechCrunch (00:33:20) Lovable becomes a unicorn with $200M Series A just 8 months after launch | TechCrunch (00:34:55) SpaceX commits $2 billion to xAI as Musk steps up AI ambitions: Report | World News - Business Standard Research & Advancements (00:35:59) A former OpenAI engineer describes what it's really like to work there | TechCrunch (00:38:23) Reasoning or Memorization? Unreliable Results of Reinforcement Learning Due to Data Contamination Policy & Safety (00:42:14) Anthropic, Google, OpenAI, xAI granted up to $200 million from DoD (00:43:08) California State Senator Scott Wiener Pushes Bill to Regulate AI Companies - Bloomberg (00:43:58) AI 'Nudify' Websites Are Raking in Millions of Dollars | WIRED (00:45:55) Inside ICE's Supercharged Facial Recognition App of 200 Million Images Synthetic Media & Art (00:48:47) Video game actors' strike officially ends after AI deal

在任何一个行业，巨头和巨头的直接舆论战都是少见现象。一旦发生，往往意味着行业正在发生重大趋势转变。而在不久前，功效护肤品领域的两大本土巨头——巨子生物和华熙生物——就展开一场舆论攻防，而争论的焦点是巨子生物的拳头产品“可复美胶原棒”。事实上，这一产品背后正是国产护肤品公司过去几年的一条经典崛起路线：通过技术研发把核心成分产业化-从医美行业切入构建高端品牌认知-借用线上渠道向大众市场普及。这条路线当中的核心理念就是“成分党”，即利用实打实的成分和功效，来冲击消费者的固有认知。成分党是过去一段时间护肤品领域最重要的行业趋势，它祛魅了诸多护肤品的传统营销话语，但同时又建立起了自己的话语。而当话语之间产生冲突时，矛盾就会爆发。| 主播 |肖文杰、约小亚| 时间轴 |02:08 巨头“做空”巨头06:44 范代娣是知识改变命运的代表08:55 械字号和成分党12:08 直播电商让巨子生物变成巨头，但也让它失去不少17:45 关于胶原棒的争议，究竟谁对谁错？20:52 满眼都是当年的自己27:29 争夺的是什么话语权？| 延伸资料 |《第一财经》杂志 - 巨子生物：成分党难逃派系斗争Advancements in Clinical Utilization of Recombinant Human Collagen: An Extensive ReviewRegulatory Landscape of Recombinant Collagen in China: From Cosmetics to Foods成都日报 - 产经晚参｜“妆字号”赛道拥挤 美妆行业展开“械”斗？21世纪经济报道 - 罕见！9家券商集体被怼，有研报已删文，部分机构道歉，行业协会发声巨子生物再回应可复美配方争议，承认检测方法存在局限性经济日报 - 玻尿酸两强：昔日兄弟，今日互撕《商业就是这样》鼓起勇气开设听友群啦。欢迎添加节目同名微信，加入听友群，一起讨论有意思的商业现象。微信号：thatisbiz为了营造更好的讨论环境，我们准备了两个小问题，请在添加微信后回答：1，你最喜欢《商业就是这样》的哪期节目？为什么？2，你希望听到《商业就是这样》聊哪个话题？期待与你交流！| 后期制作 |秋秋| 声音设计 |刘三菜| 收听方式 |你可以通过小宇宙、苹果播客、Spotify、喜马拉雅、网易云音乐、QQ 音乐、荔枝、豆瓣等平台收听节目。| 认识我们 |微信公众号：第一财经 YiMagazine联系我们：thatisbiz@yicai.com

Paul Hutchinson, a successful entrepreneur turned passionate advocate, joins us to shed light on the urgent issue of child trafficking. From his transformation from a wealthy businessman to a determined rescuer of children, Paul's journey is both heart-wrenching and inspiring. As an independent producer of the film "The Sound of Freedom" and the author of a forthcoming book by the same name, Paul offers a unique perspective on the global crisis of child trafficking and the pressing need for proactive measures to protect vulnerable children. He shares how a mission to rescue over a hundred children in Colombia profoundly changed his life, redirecting his focus toward impactful philanthropy and meaningful action.   Our conversation explores the intersection of wealth, philanthropy, and societal responsibility, with Paul reflecting on the mentor's advice that spurred his commitment to giving back. By dedicating a significant portion of his income to charitable causes, Paul discovered a new sense of purpose and fulfillment, challenging conventional notions of wealth and success. We delve into the societal impacts of technological advancements, the importance of open family communication to prevent abuse, and the hidden dangers lurking in digital interactions. With heartfelt personal anecdotes, Paul emphasizes the crucial role each of us can play in combating trafficking and exploitation.   Listeners will also gain insight into Paul's transformative experiences during healing retreats, which shaped his approach to both his personal and professional life. From confronting personal demons to gaining a deeper understanding of empathy and interconnectedness, these moments illustrate the power of introspection and growth. As we navigate topics ranging from religious affinity fraud to the importance of finding true happiness through giving, Paul's story serves as a poignant reminder of the profound difference one person can make in the world. Tune in to be inspired and motivated to join the fight against child trafficking, armed with knowledge and compassion.   CHAPTERS    (00:00) - Rescuing Children From Trafficking (04:14) - Philanthropy, Wealth, and Giving Back (14:54) - Advancements in Technology and Society (19:46) - A Rich Playboy's Heartfelt Transformation (32:14) - Protecting Children From Human Trafficking (35:23) - Online Dangers and Blackmail Extortion (39:26) - Sound of Freedom Book Discussion (42:39) - Healing and Transformation Retreat Experiences (55:24) - Religious Affinity Fraud and Morality (01:00:39) - Finding True Happiness Through Giving  

Technologists and leaders will be interested in hearing Mike explain how 3M's R&D culture that emphasizes collaborative problem-solving. They continue to leverage their "15% time" philosophy to fosters creative solutions that are being applied to our rapidly electrifying world. If you're passionate about how fundamental material science is enabling breakthrough innovation in the electrical engineering world, this is an episode you don't want to miss.  : -The Surprising Role of Adhesives and Tapes: A look at how 3M's advanced materials are critical components in everything from wind turbines to EV battery packs and motors.     -Solving Thermal Runaway in Batteries: An engineer's perspective on the challenge of preventing cell-to-cell propagation during thermal runaway and the novel materials being designed to maintain electrical insulation at extreme temperatures.     -Innovations in Electric Motor Design: A discussion on the latest trends to boost motor efficiency and simplify manufacturing, including advanced cooling strategies and the development of an expandable slot liner that incorporates adhesive.     -Digital Twins and the R&D Cycle: How simulation and digital twins are used to model complex, chaotic events like thermal runaway, significantly reducing the development and iteration time for new technologies.     

In this episode of the Boost Your Biology podcast, Lucas Aoun interviews Dr. Jonathann Kuo, an expert in longevity science and the founder of Extension Health. They discuss Dr. Kuo's journey into regenerative medicine, the shift in pain management practices, the significance of the vagus nerve, and innovative therapies such as plasmapheresis and hyperbaric therapy. The conversation also covers the role of peptides in health optimization, advancements in weight loss therapies, and the future of stem cell research. Dr. Kuo shares insights on the importance of personalized medicine and the exciting developments in the field of longevity.Relevant links:Dr Jonathan Kuo's IG: https://www.instagram.com/dr.kuo/ Check Out My Website For Coaching, Recommended Products and Much More:https://www.boostyourbiology.com/ Disclaimer:The information provided in this podcast episode is for entertainment purposes and is NOT MEDICAL ADVICE. The products presented and discussed in this podcast are explicitly only relevant to those who reside in the US. The statements and discussions held within this episode, are NOT approved by the TGA. If you have any questions about your health, contact a medical professional. This content is strictly the opinions of Lucas Aoun and is for informational and entertainment purposes only. It is not intended to provide medical advice or to take the place of medical advice or treatment from a personal physician. All viewers of this content are advised to consult with their doctors or qualified health professionals regarding specific health questions. Neither Lucas Aoun nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this content. All consumers of this content especially taking prescription or over-the-counter medications should consult their physician before beginning any nutritional, supplement or lifestyle program.Chapters00:00 Introduction to Longevity Science02:54 Journey into Regenerative Medicine05:50 The Shift in Pain Management08:51 Understanding the Vagus Nerve11:45 Neuro Reset Procedure Explained14:24 Peptides and Their Role in Health17:16 Advancements in Weight Loss Therapies20:05 The Future of Stem Cell Research22:53 Plasmapheresis and Its Benefits25:53 Hyperbaric Therapy Insights28:43 Innovations in Peptide Delivery31:32 The Role of AI in Medicine34:25 Future Directions for Extension Health Hosted on Acast. See acast.com/privacy for more information.

In this episode, CancerNetwork® spoke with breast oncologists Heather McArthur, MD; Erika Hamilton, MD; Hope Rugo, MD; and Paolo Tarantino, MD, PhD, about advances in breast cancer. These developments included recent drug approvals and ongoing research for therapeutic approaches, particularly in the areas of antibody-drug conjugates (ADCs) and CDK4/6 inhibitors, based on presentations they gave at the 25th Annual International Congress on the Future of Breast Cancer (IBC) East in New York City. Initially, McArthur, Komen Distinguished Chair in Clinical Breast Cancer Research at the Harold C. Simmons Comprehensive Cancer Center, discussed immunotherapy use in high-risk triple-negative and HER2-positive disease, the evolving role of adjuvant CDK4/6 inhibition in HER2-negative breast cancer, and potentially transformative advancements in early breast cancer treatment.  She highlighted the FDA approval for pembrolizumab (Keytruda) in early-stage triple-negative breast cancer, promising clinical trials in estrogen receptor (ER)–positive high-risk early-stage breast cancer, and data from an investigator-initiated trial to treat HER2-positive disease. Additionally, she highlighted an 8.5% improvement in pathological complete response with pembrolizumab added to immunotherapy in the phase 3 KEYNOTE-756 trial (NCT03725059), adding that a further event-free survival benefit may complicate the landscape for CDK4/6 inhibition based on lung and liver toxicities associated with the coadministration of these inhibitors with immunotherapy.1 McArthur expressed further excitement for ADC-based combinations for triple-negative disease, as well as in the high-risk residual disease setting. In addition, she highlighted potential advancements in de-escalation strategies and further considerations for ADCs in the HER2-positive and hormone receptor (HR)–positive spaces. Then, Hamilton, director of Breast Cancer and Gynecologic Cancer Research at the Sarah Cannon Research Institute, highlighted emerging therapies for early breast cancer, as well as her use of datopotamab deruxtecan-dlnk (dato-DXd; Datroway) and fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) given their recent approvals in various breast cancer subtypes. She also touched upon challenges with respect to the implementation of new therapies for early breast cancer into clinical practice. She initially highlighted new data from the phase 3 VERITAC-2 trial (NCT05654623) presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.2 Specifically, findings showed that vepdegestrant, an oral proteolysis-targeting chimera (PROTAC), exhibited an efficacy advantage over fulvestrant (Faslodex) in patients with ESR1-mutant ER-positive, HER2-negative advanced or metastatic disease. Moreover, she highlighted data from the phase 3 DESTINY-Breast09 (NCT04784715) of T-DXd in various combinations for patients with HER2-positive metastatic breast cancer.3 Hamilton further highlighted her implementation of T-DXd into clinical practice, citing her use of the agent in patients with metastatic disease, including those with HER2-low and HER2-ultralow breast cancer. She further differentiated dato-DXd from T-DXd, suggesting that they were different classes of drugs due to their different targets: TROP2 vs HER2. She concluded by highlighting an unmet need regarding sustained benefit from endocrine therapy in HR-positive disease, as well as for ADC sequencing and mechanisms of resistance. Afterward, Rugo, division chief of Breast Medical Oncology, Women's Cancer Program Director, and professor in the Department of Medical Oncology and Therapeutics Research at City of Hope, discussed efficacy and safety considerations for CDK4/6 inhibitors in early breast cancer treatment. Specifically, she highlighted their high tolerability despite adverse effects and costs associated with their use. Rugo further touched upon a reduction of recurrence rates associated with CDK4/6 inhibition, although longer-term follow-up data were warranted to optimize the duration of therapy and elucidate survival outcomes. Finally, Tarantino, a research fellow at the Dana-Farber Institute, concluded by discussing sequencing strategies for ADCs, as well as which breast cancer settings or patient populations will experience the greatest impact with this treatment modality. Tarantino discussed his use of the “sandwich strategy,” where he switches the mechanism of action of treatment after using a TOPO1 ADC. Furthermore, Tarantino highlighted data from the DESTINY-Breast09 and phase 3 ASCENT-04 (NCT06100874) trials, which displayed the enhanced efficacy of 2 ADC combination therapies.4 He concluded by discussing future considerations for combining multiple ADCs. References 1. Cardoso F, O'Shaughnessy J, Liu Z, et al. Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2- breast cancer: a randomized phase 3 trial. Nat Med. 2025;31(2):442-448. doi:10.1038/s41591-024-03415-7 2. Hamilton E, De Laurentiis M, Jhaveri K, et al. Vepdegestrant, a PROTAC estrogen receptor (ER) degrader, vs fulvestrant in ER-positive/human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer: results of the global, randomized, phase 3 VERITAC-2 study. J Clin Oncol. 2025;43(suppl 17):LBA1000. doi:10.1200/JCO.2025.43.17_suppl.LBA1000 3. Tolaney S, Jiang Z, Zhang Q, et al. Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2–positive (HER2+) advanced/metastatic breast cancer (a/mBC): interim results from DESTINY-Breast09. J Clin Oncol. 2025;43(suppl 17):LBA1008. 4. Tolaney SM, de Azambuja E, Kalinsky K, et al. Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the randomized phase 3 ASCENT-04/KEYNOTE-D19 study. J Clin Oncol. 2025;43(suppl 17):LBA109. doi:10.1200/JCO.2025.43.17_suppl.LBA109

Are your current stroke interventions in line with the latest clinical data? Dr. Blaise Baxter, interventional radiologist at Sutter Health, and Dr. Jim Milburn, interventional neuroradiologist at the Ochsner Health, join host Dr. Michael Barraza to discuss the latest advancements in stroke interventions. --- This podcast is supported by: Imperative Carehttps://imperativecare.com/stroke/zoom-stroke-solution/ --- SYNPOSIS The episode begins with a discussion on the different pathways to becoming a neurointerventionalist, emphasizing why interventional radiologists are uniquely equipped for this transition. They dive into cutting-edge stroke interventions, sharing key takeaways from major trials on large core and medium vessel occlusions. Dr. Baxter and Dr. Milburn highlight the HERMES trial, which showed that endovascular thrombectomy led to beneficial effects on patients with anterior circulation occlusion. They then cover the BAOCHE trial, which showed better functional outcomes with thrombectomy over medical therapy. Milburn and Baxter also share their perspectives on the shifting role of perfusion imaging and why the field may be moving beyond it. To close the discussion, the doctors underscore the powerful impact of rehabilitation in driving patient recovery, and stress the ongoing need for innovation and improved training in the field of neurointerventional radiology. --- TIMESTAMPS 00:00 - Introduction06:18 - Training and Certification in Neurointervention13:11- Large Core Trials and Their Impact19:42 - CT Perfusion and Treatment Decisions29:45 - Understanding Stroke Scale Scores and ICAD30:31 - Thrombectomy Trials and Treatment Strategies34:48 - Challenges in Randomizing Patients for Trials44:25 - Advancements in Robotics and Stroke Treatment51:37 - Future Directions in Stroke Rehabilitation53:11 - Global Thrombectomy Adoption and Training --- RESOURCES Hermes trial: Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731. doi:10.1016/S0140-6736(16)00163-X BAOCH trial: Jovin TG, Li C, Wu L, et al. Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2022;387(15):1373-1384. doi:10.1056/NEJMoa2207576

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden interviews Dr. Alan Bauman, a leading expert in hair restoration. They discuss Dr. Bauman's journey into the field, the evolution of hair transplantation techniques, and the importance of scalp health and nutrition in hair restoration. Dr. Bauman shares insights on the advancements in Follicular Unit Extraction (FUE), the future of hair cloning, and the role of personalized regenerative treatments. The conversation emphasizes the significance of taking action against hair loss and the exciting developments in regenerative medicine.   For Audience ·       Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !    Takeaways ·       Dr. Bauman's journey into hair transplantation began unexpectedly. ·       The evolution of hair restoration techniques has significantly improved outcomes. ·       Follicular Unit Extraction (FUE) is a less invasive method for hair transplants. ·       Scalp health is crucial for successful hair restoration. ·       Nutritional status impacts hair growth and restoration. ·       Innovative treatments like exosomes are enhancing hair restoration results. ·       The future of hair cloning holds promise for unlimited hair supply. ·       Personalized regenerative treatments are becoming more accessible. ·       Legal changes are opening doors for regenerative medicine. ·       Patient engagement is key to successful hair restoration journeys.   Chapters 00:00 Introduction to Hair Restoration and Dr. Bauman's Journey 02:54 Evolution of Hair Transplant Techniques 05:38 The Shift to Follicular Unit Extraction (FUE) 08:27 Innovations in Hair Transplant Technology 11:18 Understanding Hair Follicle Health and Growth 14:22 Holistic Approaches to Hair Restoration 17:03 Nutritional Factors in Hair Health 18:27 Holistic Approaches to Hair Restoration 19:36 Scalp Health and Its Impact on Hair Growth 21:01 Optimizing Recovery with Nutrition and Therapies 22:22 Innovative Treatments for Scarring and Healing 23:39 Transformational Stories in Hair Restoration 24:46 The Concept of Living Young for a Lifetime 25:50 Advancements in Hair Cloning Technology 28:32 Personalized Regenerative Medicine in Hair Treatments 30:35 Combining Treatments for Enhanced Results 32:40 Regulatory Changes in Regenerative Medicine 36:06 Access to Innovative Treatments and Clinical Trials   To learn more about Dr. Alan Bauman: Email: alanjbauman@me.com Website: https://www.baumanmedical.com/ Facebook: https://www.facebook.com/alanjbauman LinkedIn: https://www.linkedin.com/in/alanjbauman/ Instagram:  https://www.instagram.com/DrAlanBauman/   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw 

Make way for the next wave of GenAI..... Agentic AI Browsers. And while we've seen rumors that OpenAI is going all-in on an AI browser, the first big player is already here in Perplexity's Comet Browser. Join us as we break down how Perplexity Comet works, what makes it different, and 5 Business Use-Cases for ROI. Square keeps up so you don't have to slow down. Get everything you need to run and grow your business—without any long-term commitments. And why wait? Right now, you can get up to $200 off Square hardware at square.com/go/jordan. Run your business smarter with Square. Get started today.Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion:Thoughts on this? Join the convo and connect with other AI leaders on LinkedIn.Upcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: info@youreverydayai.comConnect with Jordan on LinkedInTopics Covered in This Episode:Rise of Agentic AI Browsers ExplainedPerplexity Comet's Hybrid AI ArchitectureLocal vs. Virtual Browser Agentic WorkflowsPerplexity Comet Key Features and AccessConnecting Google Services with Comet BrowserAgentic AI Browser Live Demo Use CasesMulti-Platform Personalized Business ResearchAutomated Market Research and Competitive AnalysisPerplexity Comet Cross-Tool Workflow AutomationAgentic AI Browsers vs. Traditional AI ChatbotsTimestamps:00:00 Everyday AI for Business Pros04:56 Agentic AI Browsers Revolutionizing Tech07:49 Advancements in AI Computer Agents09:55 Comet: Chromium-Based Browser Essentials14:43 Streamlining Tasks with Perplexity Integration19:01 AI-Powered Google Drive Personalization21:24 Square: Trusted Business Payment Solutions25:53 Preparing Keynote on Agentic AI29:59 Agentic AI: Revolutionizing Web Browsers31:56 "Agentic AI to Revolutionize Workflows"34:46 Streamlined Scheduling and Market AnalysisKeywords:Perplexity Comet, agentic AI browser, agentic AI, AI browser, business use cases, ROI, Perplexity app, hybrid AI, cloud AI, on-device AI, Comet browser, Chromium, browser automation, multi-platform research, deep research modes, AI desktop assistant, iOS assistant, Google Chrome, browser workflows, Chrome extensionSend Everyday AI and Jordan a text message. (We can't reply back unless you leave contact info) Square keeps up so you don't have to slow down. Get everything you need to run and grow your business—without any long-term commitments. And why wait? Right now, you can get up to $200 off Square hardware at square.com/go/jordan. Run your business smarter with Square. Get started today.

Dr. Camran Nezhat is world renowned for his work in minimally invasive and robotic surgery, and he specializes in treating people with endometriosis. He is best known for inventing video-assisted endoscopy and was the first to perform groundbreaking advances in minimally invasive surgical procedures that have helped millions of patients around the globe. Without his contributions, we would not have video-assisted laparoscopy as we know it. To say that it's an honor to have him on the show is an understatement! In 2020, Dr. Nezhat was chosen by the AMA as an exceptional innovator whose contributions have revolutionized modern day surgery, and for that work he received the Distinguished Service Award for meritorious service in the science and art of medicine. He's joining me today to talk about endometriosis, its treatment, and the role that minimally invasive surgery plays in assisting patients. Read the full show notes on Dr. Aimee's website You can find Dr. Camran Nezhat's website here. Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, August 18, 2025 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.     Click to find The Egg Whisperer Show podcast on your favorite podcasting app.   Watch videos of Dr. Aimee answer Ask the Egg Whisperer Questions on YouTube.   Sign up for The Egg Whisperer newsletter to get updates   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

Our 216th episode with a summary and discussion of last week's big AI news! Recorded on 07/11/2025 Hosted by Andrey Kurenkov and Jeremie Harris. Feel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.ai Read out our text newsletter and comment on the podcast at https://lastweekin.ai/. In this episode: xAI launches Grok 4 with breakthrough performance across benchmarks, becoming the first true frontier model outside established labs, alongside a $300/month subscription tier Grok's alignment challenges emerge with antisemitic responses, highlighting the difficulty of steering models toward "truth-seeking" without harmful biases Perplexity and OpenAI launch AI-powered browsers to compete with Google Chrome, signaling a major shift in how users interact with AI systems Meta study reveals AI tools actually slow down experienced developers by 20% on complex tasks, contradicting expectations and anecdotal reports of productivity gains Timestamps + Links: (00:00:10) Intro / Banter (00:01:02) News Preview       Tools & Apps (00:01:59) Elon Musk's xAI launches Grok 4 alongside a $300 monthly subscription | TechCrunch (00:15:28) Elon Musk's AI chatbot is suddenly posting antisemitic tropes (00:29:52) Perplexity launches Comet, an AI-powered web browser | TechCrunch (00:32:54) OpenAI is reportedly releasing an AI browser in the coming weeks | TechCrunch (00:33:27) Replit Launches New Feature for its Agent, CEO Calls it ‘Deep Research for Coding' (00:34:40) Cursor launches a web app to manage AI coding agents (00:36:07) Cursor apologizes for unclear pricing changes that upset users | TechCrunch       Applications & Business (00:39:10) Lovable on track to raise $150M at $2B valuation (00:41:11) Amazon built a massive AI supercluster for Anthropic called Project Rainier – here's what we know so far (00:46:35) Elon Musk confirms xAI is buying an overseas power plant and shipping the whole thing to the U.S. to power its new data center — 1 million AI GPUs and up to 2 Gigawatts of power under one roof, equivalent to powering 1.9 million homes (00:48:16) Microsoft's own AI chip delayed six months in major setback — in-house chip now reportedly expected in 2026, but won't hold a candle to Nvidia Blackwell (00:49:54) Ilya Sutskever becomes CEO of Safe Superintelligence after Meta poached Daniel Gross (00:52:46) OpenAI's Stock Compensation Reflect Steep Costs of Talent Wars       Projects & Open Source (00:58:04) Hugging Face Releases SmolLM3: A 3B Long-Context, Multilingual Reasoning Model - MarkTechPost (00:58:33) Kimi K2: Open Agentic Intelligence (00:58:59) Kyutai Releases 2B Parameter Streaming Text-to-Speech TTS with 220ms Latency and 2.5M Hours of Training       Research & Advancements (01:02:14) Does Math Reasoning Improve General LLM Capabilities? Understanding Transferability of LLM Reasoning (01:07:58) Measuring the Impact of Early-2025 AI on Experienced Open-Source Developer Productivity (01:13:03) Mitigating Goal Misgeneralization with Minimax Regret (01:17:01) Correlated Errors in Large Language Models (01:20:31) What skills does SWE-bench Verified evaluate?       Policy & Safety (01:22:53) Evaluating Frontier Models for Stealth and Situational Awareness (01:25:49) When Chain of Thought is Necessary, Language Models Struggle to Evade Monitors (01:30:09) Why Do Some Language Models Fake Alignment While Others Don't? (01:34:35) Positive review only': Researchers hide AI prompts in papers (01:35:40) Google faces EU antitrust complaint over AI Overviews (01:36:41) The transfer of user data by DeepSeek to China is unlawful': Germany calls for Google and Apple to remove the AI app from their stores (01:37:30) Virology Capabilities Test (VCT): A Multimodal Virology Q&A Benchmark

Dr. Abe Delpassand, Founder, CEO, and Chairman of the Board at RadioMedix, is concentrated on the development of radiopharmaceuticals for cancer diagnosis and treatment. Advancements in handling radioactive materials and increased availability have enabled the growth of the use of alpha-emitting and beta-emitting radioisotopes in treating cancers that have been resistant to other therapies. Alpha-emitting radioisotopes are particularly interesting because they can cause double-strand DNA damage in cancer cells, making the probability of cancer recurrence much less likely. Abe explains, "Just a brief introduction related to what radiopharmaceuticals are. These are drugs that have three parts, basically. One part is the radioactive material. The second part is what we call a ligand. It's like a vehicle that takes the radioactive material to the target that we have. And there is a third component, which is like a chain attaching the radioisotope to the ligand. Radiopharmaceuticals qualify as a form of therapy because we target a specific receptor antigen metabolic pathway in cancer cells, and this is how we can reach the cancer cells. It has two components: one, diagnostic and therapeutic, which is very unique to this modality because in many other cancer therapies before the treatment, we don't have any way to make sure that the patient who is receiving the treatment, that actually the drug can reach the cancer the patient has." "We have been talking about the value of alpha-emitters in delivering high level of radiation in a targeted fashion to the cancer cells, but we in the last, I'd say 10 years or more, we have learned how to handle these isotopes. That's one aspect of the science part. The other aspect is the availability of these isotopes. Now the supply of these isotopes is becoming a lot more, and they are becoming more available."    #RadioMedix #TeamRadioMedix #Radiopharmaceuticals #TargetedAlphaTherapy #OncologyInnovation #NuclearMedicine #CancerResearch #RadiogandTherapy #PrecisionOncology #Theranostics #SPICACenter #OncologyCommunity #AlphaEmittingRadioisotopes #BetaEmittingRadioisotopes radiomedix.com Download the transcript here

Dr. Abe Delpassand, Founder, CEO, and Chairman of the Board at RadioMedix, is concentrated on the development of radiopharmaceuticals for cancer diagnosis and treatment. Advancements in handling radioactive materials and increased availability have enabled the growth of the use of alpha-emitting and beta-emitting radioisotopes in treating cancers that have been resistant to other therapies. Alpha-emitting radioisotopes are particularly interesting because they can cause double-strand DNA damage in cancer cells, making the probability of cancer recurrence much less likely. Abe explains, "Just a brief introduction related to what radiopharmaceuticals are. These are drugs that have three parts, basically. One part is the radioactive material. The second part is what we call a ligand. It's like a vehicle that takes the radioactive material to the target that we have. And there is a third component, which is like a chain attaching the radioisotope to the ligand. Radiopharmaceuticals qualify as a form of therapy because we target a specific receptor antigen metabolic pathway in cancer cells, and this is how we can reach the cancer cells. It has two components: one, diagnostic and therapeutic, which is very unique to this modality because in many other cancer therapies before the treatment, we don't have any way to make sure that the patient who is receiving the treatment, that actually the drug can reach the cancer the patient has." "We have been talking about the value of alpha-emitters in delivering high level of radiation in a targeted fashion to the cancer cells, but we in the last, I'd say 10 years or more, we have learned how to handle these isotopes. That's one aspect of the science part. The other aspect is the availability of these isotopes. Now the supply of these isotopes is becoming a lot more, and they are becoming more available."    #RadioMedix #TeamRadioMedix #Radiopharmaceuticals #TargetedAlphaTherapy #OncologyInnovation #NuclearMedicine #CancerResearch #RadiogandTherapy #PrecisionOncology #Theranostics #SPICACenter #OncologyCommunity #AlphaEmittingRadioisotopes #BetaEmittingRadioisotopes radiomedix.com Listen to the podcast here

TAKEAWAYSWhen the antichrist comes on the scene, he'll be given the keys to the global kingdom and Ken believes the antichrist is alive todayThere is a coming financial collapse that will be necessary to usher in the End TimesInvest in hard assets - like gold - to protect yourself and transfer your funds from the big banks to a local credit unionKlaus Schwab, the son of former Nazi Eugen Schwab, of the World Economic Forum is continuing the evil agenda of Adolf Hitler

Please Support the Podcast: If you are enjoying, do me a small favour which helps a lot - subscribe and leave a review on your preferred podcast platform. Your support helps us bring valuable conversations like this one to a wider audience. Today I sit down with Martijn Arns, a biological psychologist at the forefront of applied neuroscience, to discuss the advancements and challenges in psychiatry. We delve into his pioneering research on brain biomarkers, the promising applications of brain stimulation techniques like Transcranial Magnetic Stimulation (TMS), and how lifestyle factors may influence conditions such as ADHD. Martijn also shares cutting-edge insights into the role of heart-brain coupling and the potential impact of psychedelics in mental health treatment, offering a glimpse into the future of personalised and stratified psychiatry. What You'll Learn: Understanding Biological vs. Clinical Psychology: Martijn explains the focus of biological psychology in studying brain activity rather than engaging in traditional talk therapy. The Role of Biomarkers in Psychiatry: Discover the challenges of seeking biological signatures for psychiatric conditions. Understand why a biomarker-driven psychiatry might be theoretically impossible due to clinical impairment and situational variables. Innovations in Brain Stimulation: Explore the mechanisms and applications of TMS for treating depression and other psychiatric disorders. Learn about the groundbreaking use of heart rate to optimise TMS targeting, enhancing treatment effectiveness. Lifestyle Factors and ADHD: Understand the significant role sleep and sunlight exposure play in ADHD symptoms. Consider the implications of lifestyle interventions in managing and reducing ADHD diagnoses. The Exciting Future of Psychiatric Treatments: Dive into how psychedelics might transform therapeutic approaches with their profound effects in combination with therapy. Reflect on the potential shift from daily medication to periodic brain stimulation treatments. Key Takeaways: Psychiatry is evolving, with innovations in neuroscience paving the way for more personalised and effective treatments. There's a growing recognition of the importance of lifestyle factors, like sleep and sunlight exposure, in influencing mental health conditions, especially ADHD. Advancements like TMS offer hope, showing potential even where conventional treatments have failed. Future therapies may focus more on brain stimulation and targeted interventions rather than a one-size-fits-all medication approach. Resources: For more insights and updates on cutting-edge neuroscience research, visit Brain Clinics at brainclinics.com. Connect with Martijn Arns on LinkedIn to follow his latest work in applied neuroscience. Share this episode with someone who might benefit from these insights—understanding and innovation in psychiatric treatment are vital as we move towards a future of tailored mental health care. 00:40 Biological vs. Clinical Psychology 01:38 Journey Through Academia and Early Career 04:04 Starting Brain Clinics and Translational Research 06:48 Challenges in Psychiatric Diagnosis 16:20 Stratified Psychiatry and Biomarkers 27:26 Transcranial Magnetic Stimulation (TMS) 31:25 Ethical Considerations in TMS Treatment 32:40 Future of Brain Stimulation Treatments 33:34 Personal Experiences with TMS and Psychedelics 34:23 TMS Applications Beyond Depression 36:02 Innovations in TMS Targeting 37:21 Heart-Brain Coupling and TMS 40:18 Exploring the Vagus Nerve and Depression 47:39 Sleep's Role in ADHD 55:59 Lifestyle Factors and ADHD 01:00:34 Exciting Ventures in Brain Research See omnystudio.com/listener for privacy information.

Ben Plumley is joined by Professor Heidi Larson, Co-founder and Chair of the Global Listening Project (GLP), and Susie Barnes, Senior Vice President of Global Medical Affairs for the Vaccines Division at GSK to discuss the importance of building trust and motivating awareness about new technologies in global health. The conversation covers the collaboration between the GLP and GSK, insights from their research on trust during COVID-19, and how community engagement and innovative communication strategies play a crucial role in vaccine confidence and public health. They emphasize the need for holistic approaches to prevention and the challenges of addressing vaccine hesitancy in an evolving technological landscape. 00:00 Introduction and Podcast Overview 00:45 Episode Topic: Building Trust in New Technologies 01:09 Meet the Guests: Professor Heidi Larson and Susie Barnes 02:31 The Global Listening Project and GSK Partnership 03:44 Impact of COVID-19 on Trust and Vaccine Confidence 07:22 The Role of General Practitioners and Community Health Workers 14:41 Advancements in Vaccine Technology and Prevention 19:16 Communication Strategies in the 21st Century 28:04 AI and the Need for Multiple Listening Strands 28:42 Engaging Communities in Healthcare 29:21 The Future of Therapeutic Relationships 30:58 Challenges in Vaccine Access and Trust 33:27 Communicating Science Effectively 36:06 Global Listening Project Insights 37:38 Understanding Measles and Immune Amnesia 39:39 Balancing Individual Rights and Societal Responsibilities 42:11 Next Steps for the Global Listening Project 46:43 GSK's Commitment to Prevention and Partnership

In this episode of the podcast, host Fabian Alefeld interviews Chris Holshouser, Deputy Program Director of Maritime Systems at BlueForge Alliance. They discuss the Navy's ambitious projects, focusing on advanced technologies like additive manufacturing, supply chain optimization, and workforce development. Chris elaborates on the challenges and goals associated with the Columbia and Virginia class submarines, the importance of enhancing the maritime industrial base, and the need for skilled labor in manufacturing. The conversation also touches on the establishment of the Additive Manufacturing Center of Excellence, partnerships with various organizations, and the long-term vision for modernization and technological integration in shipbuilding. More information on the Maritime Industrial Base Additive Manufacturing Excellence training available here.   01:23 Meet Chris and BlueForge Alliance 02:37 Mission and Impact of BlueForge Alliance 04:32 Understanding the US Navy's Triad and Submarine Classes 07:03 Challenges in Modernizing the Industrial Base 12:30 Role of Additive Manufacturing in the Navy 19:26 Understanding Metallurgy in Welding 19:40 Applications and Supply Chain Impact 21:22 Certification and Qualification Process 22:42 Additive Manufacturing in Practice 24:19 Challenges and Opportunities in Additive Manufacturing 28:17 Interdisciplinary Nature of Additive Manufacturing 30:18 Evaluating Parts for Additive Manufacturing 32:54 Advancements in Additive Manufacturing 37:01 Future Directions and Call to Action  

Proudly sponsored by PyMC Labs, the Bayesian Consultancy. Book a call, or get in touch!Intro to Bayes Course (first 2 lessons free)Advanced Regression Course (first 2 lessons free)Our theme music is « Good Bayesian », by Baba Brinkman (feat MC Lars and Mega Ran). Check out his awesome work!Visit our Patreon page to unlock exclusive Bayesian swag ;)Takeaways:INLA is a fast, deterministic method for Bayesian inference.INLA is particularly useful for large datasets and complex models.The R INLA package is widely used for implementing INLA methodology.INLA has been applied in various fields, including epidemiology and air quality control.Computational challenges in INLA are minimal compared to MCMC methods.The Smart Gradient method enhances the efficiency of INLA.INLA can handle various likelihoods, not just Gaussian.SPDs allow for more efficient computations in spatial modeling.The new INLA methodology scales better for large datasets, especially in medical imaging.Priors in Bayesian models can significantly impact the results and should be chosen carefully.Penalized complexity priors (PC priors) help prevent overfitting in models.Understanding the underlying mathematics of priors is crucial for effective modeling.The integration of GPUs in computational methods is a key future direction for INLA.The development of new sparse solvers is essential for handling larger models efficiently.Chapters:06:06 Understanding INLA: A Comparison with MCMC08:46 Applications of INLA in Real-World Scenarios11:58 Latent Gaussian Models and Their Importance15:12 Impactful Applications of INLA in Health and Environment18:09 Computational Challenges and Solutions in INLA21:06 Stochastic Partial Differential Equations in Spatial Modeling23:55 Future Directions and Innovations in INLA39:51 Exploring Stochastic Differential Equations43:02 Advancements in INLA Methodology50:40 Getting Started with INLA56:25 Understanding Priors in Bayesian ModelsThank you to my Patrons for making this episode possible!Yusuke Saito, Avi Bryant, Ero Carrera, Giuliano Cruz, James Wade, Tradd Salvo, William Benton, James Ahloy, Robin Taylor,, Chad

Are we heading for a future where AI knows everything but won't bother explaining it to us?Advancements in artificial intelligence are rapidly transforming the way industries operate and influencing the future of society as a whole. AI has become a force behind breakthrough technologies such as big data analytics, robotics, and the Internet of Things (IoT). The rise of generative AI has only accelerated its adoption and broadened its impact across multiple sectors. Navigating the Displacement DilemmaIn this episode of Tech Transformed, host Trisha Pillay at EM360Tech sits down with Nigel Cannings, author and AI expert, to explore one of the most pressing questions of our time: what happens to human expertise in the age of rapid AI advancement?Nigel Cannings warns that while technology promises efficiency and faster results, it also encourages dependency. Our patience has run thin, and in our rush for instant answers, we may be undermining the very systems that develop human expertise. “I'm kind of fascinated by the change we've seen in how we process information,” Cannings reflects.He describes the displacement dilemma as the idea that tools meant to democratise knowledge could actually erode the skills and pathways that build true mastery. He worries about people losing jobs or being too dependent on technology to even start careers. “I'm really interested to talk to people who've been affected by the displacement dilemma, people who are losing their jobs, people who think they're going to lose their jobs, people who can see the erosion of expertise and skills,” Cannings explains.The Future of AIAs artificial intelligence evolves at breakneck speed, we face a harsh reality: the gap between human and AI intelligence could become so wide that we might not even understand the systems we build. Worse still, AI itself may have no incentive to help us understand it. At that point, it stops being just a tool and becomes an autonomous entity with its private reality.In 2025, Chief AI Officers report an average AI ROI of 14 per cent, as many AI programs move beyond pilot programs to larger implementations at scale. This is proof that as AI continues to evolve at an unprecedented pace, understanding its implications is important, both for industries navigating these changes and for society adapting to a new technological landscape.TakeawaysAI tools meant to democratize knowledge may erode human expertise.The displacement dilemma highlights the need for future experts.Information consumption is changing due to AI algorithms.AI relies heavily on large GPU cards for processing.Current AI models are prediction machines, not truly intelligent.Future AI may have limited intelligence in specific areas.The race in AI development is driven by financial incentives.Legislation is crucial for addressing AI's potential harms.Humans will always be needed in certain job roles.Chapters00:00 Introduction to AI and Human Expertise04:06 The Displacement Dilemma: Erosion of Expertise06:59 Changing Information Consumption in the AI Era10:07 Technical Aspects of AI: Data Centres and Encryption15:42 Limitations of AI in Scientific Discovery20:22 The Future of Superhuman AI23:23 The Race in AI Development28:18 Navigating the Future of AI LeadershipAbout Nigel...

In this episode, Jacob sits down with Karol Hausman (Co-Founder) and Danny Driess (Research Scientist) from Physical Intelligence, two of the minds behind some of the most exciting advances in robotics. They unpack the last decade of progress in AI robotics, from early skepticism to the breakthroughs powering today's generalist robot models.  The conversation covers everything from folding laundry with robots to building scalable data pipelines, the limits of simulation, and what it'll take to bring robot assistants into everyday homes. It's a wide-ranging and thoughtful look at where robotics is headed, as well as how fast we might get there. (0:00) Intro(1:31) Early Days in Robotics(2:08) Shift to Learning-Based Robotics(4:50) Challenges and Breakthroughs(8:45) Google's Role and Spin-Out Decision(15:08) Comparing Robotics to Self-Driving Cars(19:18) Hardware and Intelligence(21:05) Future Milestones and Scaling Challenges(33:23) Data Collection and Infrastructure Needs(35:49) Choosing and Tackling Complex Tasks(38:49) Evaluating Model Performance(41:28) The Role of Simulation in Robotics(44:27) Research Strategies and Hiring(48:16) Open Source and Community Impact(52:27) Advancements in Training and Model Efficiency(58:45) Future of Robotics and AI(1:01:16) Quickfire With your co-hosts: @jacobeffron - Partner at Redpoint, Former PM Flatiron Health @patrickachase - Partner at Redpoint, Former ML Engineer LinkedIn @ericabrescia - Former COO Github, Founder Bitnami (acq'd by VMWare) @jordan_segall - Partner at Redpoint

In this episode of the Diabetes Innovators Series, Jake Leach, President and COO of Dexcom, discusses the evolution of Dexcom's continuous glucose monitoring (CGM) technology, its integration with other health technologies, and the impact on diabetes management. He highlights the importance of awareness and access to CGM for type 2 diabetes patients, the advancements in product reliability, and the future innovations that Dexcom is working on to enhance user experience and improve diabetes care. Chapters 00:00 Introduction to Dexcom and Jake Leach 01:23 The Evolution of Continuous Glucose Monitoring 05:15 Integration with Health Technologies 07:44 Advancements in Diabetes Management 10:27 Product Quality and User Experience 15:31 Looking Ahead: ADA Conference Insights Resources: Dexcom Jake Leach LinkedIn

Our 215th episode with a summary and discussion of last week's big AI news! Recorded on 07/04/2025 Hosted by Andrey Kurenkov and Jeremie Harris. Feel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.ai Read out our text newsletter and comment on the podcast at https://lastweekin.ai/. In this episode: Cloudflare's new AI data scraper blocking feature, its potential implications, and technical challenges Meta's aggressive recruitment for its Super Intelligence Labs division is covered, highlighting key hires from OpenAI and other leaders in the field Anthropic loses significant talent to Cursor, with details on their new economic futures program focusing on AI's impact on the labor market Notable open-source AI model releases from Baidu and Tencent are also discussed, including their performance metrics and potential applications. Timestamps + Links: (00:00:11) Intro / Banter (00:01:43) News Preview Tools & Apps (00:02:55) Cloudflare Introduces Default Blocking of A.I. Data Scrapers (00:05:44) Runway is going to let people generate video games with AI (00:11:24) Google embraces AI in the classroom with new Gemini tools for educators, chatbots for students, and more (00:16:23) No one likes meetings. They're sending their AI note takers instead. (00:18:08) Google launches Doppl, a new app that lets you visualize how an outfit might look on you (00:19:14) Google's Imagen 4 text-to-image model promises 'significantly improved' boring images Applications & Business (00:22:18) Mark Zuckerberg announces his AI ‘superintelligence' super-group (00:29:35) Anthropic Revenue Hits $4 Billion Annual Pace as Competition With Cursor Intensifies (00:35:10) As job losses loom, Anthropic launches program to track AI's economic fallout (00:38:04) OpenAI says it has no plan to use Google's in-house chip (00:41:08) Nvidia stakes new startup that flips script on data center power (00:44:11) TSMC Arizona Chips Are Reportedly Being Flown Back to Taiwan For Packaging; U.S. Semiconductor Supply Chain Still Remains Dependent on Taiwan Projects & Open Source (00:46:57) Baidu releases open source model family ERNIE 4.5 (00:51:55) Tencent Open Sources Hunyuan-A13B: A 13B Active Parameter MoE Model with Dual-Mode Reasoning and 256K Context (00:57:09) Together AI Releases DeepSWE: A Fully Open-Source RL-Trained Coding Agent Based on Qwen3-32B and Achieves 59% on SWEBench (01:00:11) GLM-4.1V-Thinking: Towards Versatile Multimodal Reasoning with Scalable Reinforcement Learning (01:04:10) DiffuCoder: Understanding and Improving Masked Diffusion Models for Code Generation Research & Advancements (01:06:21) Wider or Deeper? Scaling LLM Inference-Time Compute with Adaptive Branching Tree Search (01:13:07) The Automated LLM Speedrunning Benchmark: Reproducing NanoGPT Improvements (01:18:04) Claude 4 Opus and Sonnet reach 50%-time-horizon point estimates of about 80 and 65 minutes, respectively (01:21:37) Performance Prediction for Large Systems via Text-to-Text Regression (01:25:38) Does Math Reasoning Improve General LLM Capabilities? Understanding Transferability of LLM Reasoning (01:26:33) Correlated Errors in Large Language Models Policy & Safety (01:29:04) Forecasting Biosecurity Risks from LLMs (01:36:06) AI Task Length Horizons in Offensive Cybersecurity (01:42:30) Inside Tech's Risky Gamble to Kill State AI Regulations for a Decade (01:52:56) Denmark to tackle deepfakes by giving people copyright to their own features

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentExciting news in the world of oncology as a new breakthrough in cancer treatment has been announced. Researchers have discovered a novel therapy that targets specific mutations in cancer cells, leading to significantly improved outcomes for patients. This groundbreaking treatment is set to revolutionize the way we approach cancer care and could potentially save countless lives in the future.## FDA Approval for New DrugIn other news, the FDA has granted approval for a new drug that shows promising results in the treatment of a rare genetic disorder. This drug has undergone rigorous testing and has been shown to be both safe and effective in clinical trials. The approval of this medication represents a major milestone in the field of rare disease treatment and offers hope to patients who previously had limited options for managing their condition.## Collaboration between Pharmaceutical CompaniesA collaboration between two leading pharmaceutical companies has been announced, with the goal of developing innovative therapies for a range of diseases. This partnership brings together the unique expertise and resources of both companies, potentially leading to the discovery of new treatments that could benefit patients worldwide. This collaboration highlights the importance of working together to address unmet medical needs and advance the field of medicine.## Advancements in Gene TherapyExciting advancements have been made in the field of gene therapy, with researchers reporting promising results in early clinical trials. Gene therapy has the potential to treat a wide range of genetic disorders by replacing or modifying faulty genes. These latest developments represent a significant step forward in the field of genetic medicine and offer hope to patients who previously had limited treatment options.## ConclusionIn conclusion, these recent developments in the world of Pharma and Biotech are not only groundbreaking but also offer hope for patients facing serious medical conditions. From breakthroughs in cancer treatment to advancements in gene therapy, the future of medicine is looking brighter than ever. Stay tuned for more updates on these exciting developments as we continue to follow the latest news in Pharma and Biotech.

FFI Practitioner is pleased to feature a podcast conversation with Dr. Kris Verburgh, who presented the keynote at the 2019 Global Conference. In today's interview, Dr. Verburgh discusses the advancements in longevity research since his 2019 keynote, highlighting significant investments to address aging-related diseases. He also explores the ways in which a shift towards an … Continue reading Advancements in Longevity Research: An Interview with Dr. Kris Verburgh →

Top AI & GPT expert shares tips on ChatGPT, AI agents, Rufus, and more. Plus, exclusive access to his private Amazon seller GPTs just for Serious Sellers Podcast listeners.   ► Instagram: instagram.com/serioussellerspodcast ► Free Amazon Seller Chrome Extension: https://h10.me/extension ► Sign Up For Helium 10: https://h10.me/signup  (Use SSP10 To Save 10% For Life) ► Learn How To Sell on Amazon: https://h10.me/ft ► Watch The Podcasts On YouTube: youtube.com/@Helium10/videos   Andrew Bell, a standout figure in the realm of AI and custom GPTs, kicks off our very first installment of AIM, our Monthly AI workshop on all things artificial intelligence. In this episode, Andrew opens up about his journey from the Moody Bible Institute to becoming an e-commerce maestro on platforms like Amazon. Growing up in the quirky town of Santa Claus, Indiana, and now living in Kentucky, Andrew captivates with his unique perspective, connecting the dots between local sports rivalries and the debates surrounding artificial intelligence. His pioneering work with Touch of Glass and his learnings from the Freedom Ticket course by Helium 10 laid the groundwork for his success, making him a voice worth listening to in the fast-paced world of e-commerce.   As we engage with Andrew, we discover the fascinating world of AI-driven tools designed for Amazon listing optimization and product research. With over 350 custom GPTs under his belt, Andrew discusses the art of prompting and how robust strategies can mitigate errors. The conversation takes a turn into the challenges faced when AI relies on outdated data, such as the myths surrounding the Amazon A10 algorithm. By blending AI with reliable resources like Helium 10's data, the episode reveals how sellers can enhance the accuracy and trust of their listings, amidst a landscape of evolving AI capabilities. Rounding out the episode, Andrew shares strategic insights for maximizing AI in product research and listing optimization. From the intricacies of using Amazon's generative AI-powered shopping assistant Rufus to the innovative application of AI reasoning models, Andrew highlights ways to maintain accurate and engaging Amazon listings. We explore the benefits of visual label tagging and new features for price alerts, all aimed at boosting conversion rates during key sales events. Don't miss Andrew's reflections on the continued evolution of AI technology and its growing impact on both personal and professional realms. For those eager to try out Andrew Bell's custom GPTs firsthand, listeners of the Serious Sellers Podcast get exclusive access. While many of his 350+ custom GPTs are still gated for private workshops and Helium 10 events, Andrew makes a few powerful ones available for our audience. Go to https://h10.me/andrewbellgpt to access a curated selection, including GPTs for product research, demand validation, e-commerce script agents, and even one cleverly titled NoMDashes, designed to remove those pesky AI giveaway dashes from your copy. These GPTs aren't available to the general public yet, so this is your chance to explore cutting-edge AI tools before they're widely released. Just one more perk of tuning in.   In episode 680 of the Serious Sellers Podcast, Bradley and Andrew discuss: 01:00 - Andrew Bell's Backstory 04:55 - Success in Amazon Seller Optimization 09:03 - Pricing Strategies Across Different Niches 11:57 - Leveraging AI for Amazon Listing Optimization 14:35 - Trust in AI and Misconceptions 17:29 - Keyword Generation in ChatGPT 20:41 - Maximizing AI for Product Research 22:36 - The Future of Data Augmentation 26:29 - Leveraging AI for Comprehensive Product Research 34:07 - E-commerce Sellers Optimizing for AI in 2025 34:19 - Amazon Listing Optimization Strategies 37:51 - Visual and Textual Content for Conversions 40:39 - Click Training Data and Customer Questions 46:04 - Advancements in Reasoning Models and AI 47:00 - Amazon Rufus and AI Reasoning Models

Send us a textIn this episode of the Life Science Success Podcast my guest is Christopher Duma, a board-certified neurosurgeon who is pioneering innovative treatments for neurodegenerative diseases at Regeneration Biomedical, Inc.00:00 Introduction to Life Science Success Podcast00:34 Meet Dr. Christopher Duma: A Pioneer in Neurosurgery00:59 Dr. Duma's Journey to Neurosurgery03:13 Challenges in Treating Neurodegenerative Diseases05:59 The Potential of Stem Cells in Neurosurgery10:06 Technological Advances in Neurosurgery13:34 Innovations in Deep Brain Stimulation15:57 Exploring Immunotherapy and Gene Therapy18:14 The Mission of Regeneration Biomedical20:15 Understanding Stem Cell Therapy for Brain Diseases27:28 FDA Trials and Initial Research28:07 Innovative Stem Cell Injection Method30:20 Phase One Trial and Results34:20 Future of Stem Cell Treatments40:30 Challenges and Advancements in Movement Disorders45:14 Leadership and Personal Insights52:50 Conclusion and Final Thoughts

Jim Love hosts Krish Banerjee, Canadian Managing Director at Accenture for AI and Data, in a discussion that spans the rapid evolution of AI, enterprise adoption, and the interplay between data and innovation. They tackle the transformation of industry practices, the growing role of AI in everyday life, and the significance of responsible AI development. Krish emphasizes the need for focusing on tangible value and the transformation of existing processes through AI, while touching on the future implications for Canada's digital sovereignty and productivity advances. 00:00 Introduction and Guest Welcome 01:06 AI Evolution and Market Shifts 02:31 Data's Crucial Role in AI 04:53 Enterprise AI: Challenges and Opportunities 13:28 Global AI Landscape and Canada's Position 24:10 Innovative AI Projects and Passionate Pursuits 25:59 Reinventing Healthcare with AI 26:52 Commercializing AI for Canadian Businesses 28:41 The Responsibility of AI Development 29:13 Economic Impact and Future Predictions of AI 33:42 Agentic AI: The Next Frontier 39:24 Democratization and Open Source AI 41:34 Advice for Executives on AI Adoption 45:23 Encouraging AI Learning in the Next Generation 47:20 Final Thoughts and Future Conversations

Our 214th episode with a summary and discussion of last week's big AI news! Recorded on 06/27/2025 Hosted by Andrey Kurenkov and Jeremie Harris. Feel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.ai Read out our text newsletter and comment on the podcast at https://lastweekin.ai/. In this episode: Meta's hiring of key engineers from OpenAI and Thinking Machines Lab securing a $2 billion seed round with a valuation of $10 billion. DeepMind introduces Alpha Genome, significantly advancing genomic research with a model comparable to Alpha Fold but focused on gene functions. Taiwan imposes technology export controls on Huawei and SMIC, while Getty drops key copyright claims against Stability AI in a groundbreaking legal case. A new DeepMind research paper introduces a transformative approach to cognitive debt in AI tasks, utilizing EEG to assess cognitive load and recall in essay writing with LLMs. Timestamps + Links: (00:00:10) Intro / Banter (00:01:22) News Preview (00:02:15) Response to listener comments Tools & Apps (00:06:18) Google is bringing Gemini CLI to developers' terminals (00:12:09) Anthropic now lets you make apps right from its Claude AI chatbot Applications & Business (00:15:54) Sam Altman takes his ‘io' trademark battle public (00:21:35) Huawei Matebook Contains Kirin X90, using SMIC 7nm (N+2) Technology (00:26:05) AMD deploys its first Ultra Ethernet ready network card — Pensando Pollara provides up to 400 Gbps performance (00:31:21) Amazon joins the big nuclear party, buying 1.92 GW for AWS (00:33:20) Nvidia goes nuclear — company joins Bill Gates in backing TerraPower, a company building nuclear reactors for powering data centers (00:36:18) Mira Murati's Thinking Machines Lab closes on $2B at $10B valuation (00:41:02) Meta hires key OpenAI researcher to work on AI reasoning models Research & Advancements (00:49:46) Google's new AI will help researchers understand how our genes work (00:55:13) Direct Reasoning Optimization: LLMs Can Reward And Refine Their Own Reasoning for Open-Ended Tasks (01:01:54) Farseer: A Refined Scaling Law in Large Language Models (01:06:28) LLM-First Search: Self-Guided Exploration of the Solution Space Policy & Safety (01:11:20) Unsupervised Elicitation of Language Models (01:16:04) Taiwan Imposes Technology Export Controls on Huawei, SMIC (01:18:22) Your Brain on ChatGPT: Accumulation of Cognitive Debt when Using an AI Assistant for Essay Writing Task Synthetic Media & Art (01:23:41) Judge Rejects Authors' Claim That Meta AI Training Violated Copyrights (01:29:46) Getty drops key copyright claims against Stability AI, but UK lawsuit continues

We use articulators to help ‘mimic' our patient's jaw movements, to ultimately do less adjustments/revisions in the future. But are digital articulators there yet? Or is analog king? Or is digital dentistry just flashy tech with no real-world benefits? Can a virtual articulator truly match the movements of your patient's jaw? Is a CBCT really better than a facebow—and WHEN should you use which? In this cutting-edge episode with Dr. Seth Atkins, we dive into the world of digital articulation—exploring how tools like virtual articulators, CBCT alignment, and 3D-printed provisionals are transforming clinical workflows. You'll learn how to combine analog wisdom with digital precision, improve lab communication, and make full-mouth rehabs more predictable and efficient than ever. From mounting accuracy to motion capture, this episode is your ultimate guide to articulating smarter in the digital age. https://www.youtube.com/watch?v=fT31Ecf_kDo Watch PDP230 on YouTube Protrusive Dental Pearl: Always send your lab the color version of your digital scan — the PLY file — not just the STL. STL shows shape, but PLY shows color — like markings and tissue detail. Ask your lab: "Are you seeing color, or do you need the PLY?" Better scans = better results Need to Read it? Check out the Full Episode Transcript below! Key Takeaways: Digital methods can enhance accuracy and patient outcomes → but only when used intentionally. Understanding both analog and digital techniques is crucial → they complement each other, not compete. Mentorship plays a significant role in advancing dental education → experience accelerates clinical confidence. Digital workflows can significantly reduce chair time → and improve patient comfort in the process. The integration of CBCT with digital workflows enhances diagnostics → giving clearer insight into static and functional relationships. Digital provisionals offer a cost-effective and efficient solution → saving time, money, and frustration for both dentist and patient. Axiography is essential for capturing patient motion accurately → because real movement matters more than assumptions. Highlights of the Episode: 00:00 Introduction 04:00  Protrusive Dental Pearl 05:32 Interview with Dr. Seth Atkins and his Journey into Digital Dentistry 08:06 The Evolution of Digital Articulation 13:38 Digital Workflow and Mentorship 20:01 Accuracy and Efficiency in Digital Dentistry 22:32 Static and Dynamic Relations in Digital Dentistry 31:01 Interjection 1 36:05 Practical Guidelines on Integrating CBCT 37:15 Interjection 2  40:59 Clinical Observations in Dental Rehabilitation 42:29 Interjection 3  45:21 Introduction to Axiography 46:40 Advancements in Digital Dentistry 49:33 3D Printing in Dental Practice 53:31 Motion Tracking on Digital Articulators 57:30 Cost Efficiency of Digital Tools 01:01:10 Alternatives to CBCT 01:05:52 Involvement with AES and Future Plans Check out the study mentioned: "Comparison of the accuracy of a cone beam computed tomography-based virtual mounting technique with that of the conventional mounting technique using facebow"

- The Truman Show and the Collapse of False Reality (0:10) - Interview with Stefan Molyneux and Enoch AI Launch (1:36) - Character Limits and Future Plans for Enoch AI (3:51) - Critique of Meta's AI and China's Advancements (6:53) - The Decentralization of Human Knowledge (11:41) - The Collapse of The Truman Show and Its Implications (12:01) - The Impact of COVID-19 and the Rise of AI (32:31) - The Role of Wearables and the Future of AI (36:22) - The Collapse of False Narratives and the Rise of Conscious Creation (40:39) - The Power of Human Consciousness and the Future of AI (47:03) - Breaking the Cycle of Humanity (1:25:51) - Critique of the Big Beautiful Bill (1:31:06) - NASA's Deception and the Extinction Level Event (1:33:08) - Globalist Agenda and Earth Shift Predictions (1:37:05) - Preparedness for Earth Changes (1:46:09) - Critique of RFK Jr. and the Maha Administration (1:49:46) - The Prep Act and Pharmaceutical Industry Liability (1:52:25) - The Role of Wearables and Surveillance (2:09:07) - The Satanic Agenda and Vaccination Strategies (2:31:08) - Chemtrails and Environmental Contamination (2:33:35) - Final Thoughts and Call to Action (2:39:28) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

In this podcast episode, Dennis and Michael discuss the critical role of hemostatic agents in hemorrhage control. Michael, a clinical education manager at Celox Medical, shares his extensive experience as a Navy corpsman and firefighter, emphasizing the importance of understanding the mechanisms of hemostatic agents, the necessity of pressure in controlling bleeding, and the impact of coagulopathy on treatment effectiveness. They also explore practical tips for effective wound packing, the significance of anatomy knowledge, and advancements in hemostatic technology. The conversation highlights the need for continuous training and understanding of medical products to ensure effective trauma care.Listen to this podcast AD-FREE with membership.TakeawaysHemostatic agents provide advantages in controlling bleeding.Pressure is essential for effective hemorrhage control.Understanding anatomy is crucial for effective wound packing.Coagulopathy can significantly affect the effectiveness of hemostatic agents.Different hemostatic agents have varying activation times.Experience and practice are vital for effective hemorrhage management.Advancements in hemostatic technology improve treatment outcomes.Knowledge of product deployment is critical in emergency situations.Training should focus on practical skills and unconscious competence.Continuous education is necessary for all medical professionals. Chapters00:00 Introduction to Hemostatic Agents03:08 Understanding the Need for Hemostatic Agents06:03 Mechanisms of Action in Hemostatic Agents09:05 The Importance of Pressure in Hemorrhage Control11:56 Activation Times and Their Significance14:56 Impact of Coagulopathy on Hemostatic Agents18:01 Practical Tips for Effective Wound Packing21:06 Understanding Anatomy for Effective Hemorrhage Control23:52 The Role of Experience in Hemorrhage Management27:05 Advancements in Hemostatic Technology30:11 Conclusion and Final Thoughts on Hemostatic AgentsThank you to Delta Development Team for in part, sponsoring this podcast.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠deltadevteam.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠⁠⁠

When patients think of palatal expanders, they may think of torture devices. But with recent advancements and technology, they are more sophisticated than ever. In this episode of Clinical Edge Fridays, Kirk Behrendt brings back Dr. Rebecca Bockow, instructor from Spear Education, to share where we are today with MARPEs and why now is the best time to offer it in your practice. To learn how you can “expand” the services you provide, listen to Episode 909 of The Best Practices Show!Learn More About Dr. Bockow:Join Dr. Bockow on Facebook: https://www.facebook.com/InspiredOrthoFollow Dr. Bockow on Instagram: https://www.instagram.com/rbockowRegister for Dr. Bockow's Healthy Growth - Healthy Faces course (September 25-27, 2025): https://www.arnettgunson.com/healthy-growth-healthy-faces-seattleMore Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 909: https://www.youtube.com/@actdental/videosMain Takeaways:MARPE doesn't replace jaw surgery but is a less invasive solution for some patients.Age is no longer an impediment to MARPEs. Patients in their 60s can have it done.We can increase predictability and reduce complications with custom designs.Advancements have reduced the need for surgical intervention in adults.Educate patients. A MARPE is not a panacea for complex issues.Now is the best time to lean into MARPEs.Snippets:0:00 Introduction.1:23 Dr. Bockow's background.5:22 Why this is an important topic.7:32 MARPEs, explained.15:05 Where we are now with MARPEs.18:35 The recovery process for patients.19:31 Age is no longer an impediment.21:04 What people get wrong about MARPEs.22:45 The future of MARPEs.25:00 Airway and periodontal implications of...

Live from Channel Partners, Jackie Steinberg, DartPoints' Channel Chief, discusses DartPoints' expanding channel presence, the impact of AI on data center demand, and new opportunities for partners in an evolving digital ecosystem. Don't miss out on this exclusive interview uncovering DartPoints' strategic advancements.

Our 213nd episode with a summary and discussion of last week's big AI news! Recorded on 06/21/2025 Hosted by Andrey Kurenkov and Jeremie Harris. Feel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.ai Read out our text newsletter and comment on the podcast at https://lastweekin.ai/. In this episode: Midjourney launches its first AI video generation model, moving from text-to-image to video with a subscription model offering up to 21-second clips, highlighting the affordability and growing capabilities in AI video generation. Google's Gemini AI family updates include high-efficiency models for cost-effective workloads, and new enhancements in Google's search function now allow for voice interactions. The introduction of two new benchmarks, Live Code Bench Pro and Abstention Bench, aiming to test and improve the problem-solving and abstention capabilities of reasoning models, revealing current limitations. OpenAI wins a $200 million US defense contract to support various aspects of the Department of Defense, reflecting growing collaborations between tech companies and government for AI applications. Timestamps + Links: (00:00:10) Intro / Banter (00:01:32) News Preview Tools & Apps (00:02:12) Midjourney launches its first AI video generation model, V1 (00:05:52) Google's Gemini AI family updated with stable 2.5 Pro, super-efficient 2.5 Flash-Lite (00:07:59) Google's AI Mode can now have back-and-forth voice conversations (00:10:13) YouTube to Add Google's Veo 3 to Shorts in Move That Could Turbocharge AI on the Video Platform Applications & Business (00:11:10) The ‘OpenAI Files' will help you understand how Sam Altman's company works (00:12:29) OpenAI drops Scale AI as a data provider following Meta deal (00:13:28) Amazon's Zoox opens its first major robotaxi production facility Projects & Open Source (00:15:20) LiveCodeBench Pro: How Do Olympiad Medalists Judge LLMs in Competitive Programming? (00:19:45) AbstentionBench: Reasoning LLMs Fail on Unanswerable Questions (00:22:49) MiniMax-M1: Scaling Test-Time Compute Efficiently with Lightning Attention Research & Advancements (00:24:33) Scaling Laws of Motion Forecasting and Planning -- A Technical Report Policy & Safety (00:28:07) Universal Jailbreak Suffixes Are Strong Attention Hijackers (00:30:52) OpenAI found features in AI models that correspond to different ‘personas' (00:33:25) OpenAI wins $200 million U.S. defense contract

What's the real threat to commercial real estate professionals?(Hint: It's not AI—it's doing things the way you've always done them.)Michael Hironimus is back, and this time he's bringing a full-on masterclass in how CRE pros can leverage AI to get ahead—before they get left behind.In this episode, we cover:

Text Dr. Lenz any feedback or questions In this episode, we delve into the ongoing research and new findings related to Chronic Fatigue Syndrome (CFS). The discussion covers the development of standardized diagnostic criteria known as the Hingston Criteria, as well as the discovery of biological abnormalities in CFS patients. Key areas of focus include the autonomic nervous system, heart rate variability, and muscle strength.  The episode also touches on the concept of 'effort preference' and the complex interplay between sympathetic and parasympathetic nervous system activity in chronic conditions like CFS and fibromyalgia. Additionally, the episode previews upcoming discussions on findings from functional MRIs of the brain in CFS patients.00:00 Introduction and Importance of Defining the Disease00:15 The Hingston Criteria: A New Standard for Clinical Trials00:59 Biological Evidence and Clinical Trials02:13 Autonomic Dysfunction in Chronic Fatigue Syndrome04:14 Sympathetic and Parasympathetic Systems Explained08:24 Chronic Stress and Its Impact on Health10:21 Comparing Functional Somatic Syndromes and Stress-Related Syndromes20:59 Muscle Strength and Cognitive Effort in CFS22:28 Understanding EMG and Its Diagnostic Value26:57 Effort Preference and Its Clinical Implications28:42 Conclusion and Next Week's Preview Joy LenzFibromyalgia 101. A list of fibromyalgia podcast episodes that are great if you are new and don't know where to start. Support the showWhen I started this podcast—and the book that came before it—I had my patients in mind. Office visits are short, but understanding complex, often misunderstood conditions like fibromyalgia takes time. That's why I created this space: to offer education, validation, and hope. If you've been told fibromyalgia “isn't real” or that it's “all in your head,” know this—I see you. I believe you. You're not alone. This podcast aims to affirm your experience and explain the science behind it. Whether you live with fibromyalgia, care for someone who does, or are a healthcare professional looking to better support patients, you'll find trusted, evidence-based insights here, drawn from my 28+ years as an MD. Please remember to talk with your doctor about your symptoms and care. This content doesn't replace personal medical advice.* ...

“Our brain is a like a VR headset. That's what it is. It renders incoming data streams to interpret different worlds,” David explained. He proposed that we already live in a symbolic universe, such as the trash can on a desktop being merely a symbol of an action taken on a computer. “VR is a much better model to explain what our brains do,” he continued. David Christopher Lane, PhD and I discussed his experiences with the worlds of Virtual Reality (VR), Artificial Intelligence (AI), and neuroscience. I noted that technology could be used for good or evil and that it is essential to have responsible, ethical guidelines for such tools. David agreed, “The bad actors using AI, just like the internet, allowed lots of people to have voices that probably should never have had voices.” He then mentioned how podcasters such as Joe Rogan broadcast a lot of messages that are “not credentialed, not great historians, believing in all sorts of weird stuff.” We spoke about developmental psychology and ideas of mature self-knowledge, including values and beliefs that allow us to investigate and evolve our systems of consciousness and decision-making. David noted that in his critical thinking class, they discussed how one becomes a good critical thinker. “It is our ability and willingness to admit to being wrong or mistaken.” This is a fascinating discussion. AI is here and will get more prominent. Come listen and learn. Learn more about your ad choices. Visit megaphone.fm/adchoices